newsfilter
← Latest News
GlobeNewswire·

Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024

DURHAM, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly